Medicare Enrolled

Dr. Margaret Vallen Mashikian, M.D.

Allergy Physician · South Weymouth, MA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
851 MAIN ST, South Weymouth, MA 02190
7813311060
Registered in NPPES since 2007
NPI: 1881751394 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Vallen Mashikian from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Vallen Mashikian? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Vallen Mashikian

Dr. Margaret Vallen Mashikian is an allergy physician in South Weymouth, MA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Vallen Mashikian performed 3,330 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Vallen Mashikian received a total of $6,963 from 27 pharmaceutical and/or device companies across 332 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Vallen Mashikian is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years of NPI registration ▲ Top 29% volume in MA $6,963 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
3,330
Medicare services
Top 29% in MA for allergy physician
Not available
Unique patients (not deduplicated)
$14
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Allergy skin test
A diagnostic test performed to identify specific allergies by applying or introducing allergenic extracts to the body. The procedure measures the patient's immune response to various potential allergens.
1,150 $3 $14
Skin allergy test
A test where small amounts of potential allergens are injected into the skin to check for allergic reactions.
810 $7 $18
Allergy injection therapy, multiple injections
A professional service involving the administration of multiple allergen injections.
397 $9 $68
Allergy immunotherapy preparation
A professional service involving the preparation and administration of one or more antigens.
393 $11 $35
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
241 $67 $200
Expiratory airflow and volume test
A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume.
123 $20 $65
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
104 $10 $63
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
39 $95 $250
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
37 $121 $350
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
22 $90 $300
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
14 $53 $150
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$6,963
Total received (2018-2024)
Avg $995/year across 7 years
Top 18% in MA for allergy physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
27
Companies
332
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,672
2023
$1,289
2022
$895
2021
$416
2020
$203
2019
$581
2018
$906

Payments by company (2024)

AstraZeneca Pharmaceuticals LP
$774
Amgen Inc.
$309
Regeneron Healthcare Solutions, Inc.
$223
Novartis Pharmaceuticals Corporation
$202
PFIZER INC.
$194
Genentech USA, Inc.
$168
Pharming Healthcare, Inc.
$158
GlaxoSmithKline, LLC.
$148
BioCryst US Sales Co., LLC
$117
Grifols USA, LLC
$92
LEO Pharma Inc.
$55
Takeda Pharmaceuticals U.S.A., Inc.
$53
Blueprint Medicines Corporation
$51
GENZYME CORPORATION
$50
kaleo, Inc.
$47
CSL Behring
$29
Top 3 companies account for 48.9% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$1,958
Genentech USA, Inc.
$535
GlaxoSmithKline, LLC.
$480
Novartis Pharmaceuticals Corporation
$418
PFIZER INC.
$371
Regeneron Healthcare Solutions, Inc.
$357
Amgen Inc.
$309
GENZYME CORPORATION
$262
Boehringer Ingelheim Pharmaceuticals, Inc.
$262
Grifols USA, LLC
$228
Pharming Healthcare, Inc.
$228
kaleo, Inc.
$207
BioCryst US Sales Co., LLC
$197
CSL Behring
$176
Bio Products Laboratory USA, Inc.
$170
Takeda Pharmaceuticals U.S.A., Inc.
$117
LEO Pharma Inc.
$117
Blueprint Medicines Corporation
$96
Shire North American Group Inc
$92
Merck Sharp & Dohme Corporation
$82
Teva Pharmaceuticals USA, Inc.
$77
ALK-Abello, Inc
$71
Kaleo, Inc.
$48
Circassia Pharmaceuticals Inc
$34
Mylan Specialty L.P.
$32
Covis Pharma GmBH
$24
Hikma Pharmaceuticals USA
$14
Top 3 companies account for 42.7% of all-time payments
Associated products mentioned in payments ›
ADBRY · AIRSUPRA · ALVESCO · ASMANEX · AUVI-Q · AYVAKIT · AirDuo Digihaler · Auvi-Q · BREO · BREZTRI · CINQAIR · CINRYZE · CUVITRU · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · Dymista · EUCRISA · FASENRA · Gammaplex · Gamunex-C · HYQVIA · Haegarda · Hizentra · NUCALA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ORLADEYO · Odactra · Prolastin-C Liquid · QVAR · RUCONEST · Ryaltris · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · XOLAIR · Xembify · Xolair
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for an allergy physician in South Weymouth?
Compare allergy physicians in the South Weymouth area by procedure volume, costs, and industry payment transparency.
Browse allergy physicians nearby

Geographic Context

Allergy physicians in nearby ZIP areas
15
County median income
$126,497
Nearest hospital to ZIP centroid (approximate)
SOUTH SHORE HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Vallen Mashikian is a mixed practice specialist, with above-average Medicare volume (top 29% in MA), with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Vallen Mashikian experienced with allergy skin test?
Based on Medicare claims data, Dr. Vallen Mashikian performed 1,150 allergy skin test services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Vallen Mashikian receive payments from pharmaceutical companies?
Yes. Dr. Vallen Mashikian received a total of $6,963 from 27 companies across 332 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Vallen Mashikian's costs compare to other allergy physicians in South Weymouth?
Dr. Vallen Mashikian's average Medicare payment per service is $14. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Vallen Mashikian) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →